How much did Pharma Foods International Co achieve in EBIT for the current year?
In the current year, Pharma Foods International Co has achieved an EBIT of 3.61 B JPY.
Pharma Foods International Co EBIT 2024
Pharma Foods International Co EBIT
3.61 B JPY
Ticker
2929.T
ISIN
JP3802310007
In 2024, Pharma Foods International Co's EBIT was 3.61 B JPY, a 234.26% increase from the 1.08 B JPY EBIT recorded in the previous year.
The Pharma Foods International Co EBIT history
| YEAR | EBIT (undefined JPY) |
|---|---|
| 2023 | 3.61 |
| 2022 | 1.08 |
| 2021 | 5.67 |
| 2020 | 0.74 |
| 2019 | 0.58 |
| 2018 | 0.3 |
| 2017 | 0.09 |
| 2016 | -0.05 |
| 2015 | -0.37 |
| 2014 | -0.03 |
| 2013 | 0.22 |
| 2012 | 0.07 |
| 2011 | -0.04 |
| 2010 | -0.06 |
| 2009 | -0.27 |
| 2008 | -0.45 |
| 2007 | -0.16 |
| 2006 | 0.17 |
| 2005 | 0 |
| 2004 | -0.02 |
Pharma Foods International Co Revenue, EBIT, Net Income JP3802310007 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Pharma Foods International Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Pharma Foods International Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Pharma Foods International Co’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Pharma Foods International Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Pharma Foods International Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Pharma Foods International Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Pharma Foods International Co’s growth potential.
Pharma Foods International Co Revenue, EBIT and net profit per share
| Date | Pharma Foods International Co Revenue | Pharma Foods International Co EBIT | Pharma Foods International Co Net Income |
|---|---|---|---|
| 2023 | 68.57 B undefined | 3.61 B undefined | 3.08 B undefined |
| 2022 | 60.19 B undefined | 1.08 B undefined | -374 M undefined |
| 2021 | 46.75 B undefined | 5.67 B undefined | 3.84 B undefined |
| 2020 | 15.35 B undefined | 740.02 M undefined | 690.95 M undefined |
| 2019 | 10.53 B undefined | 576.25 M undefined | 499.85 M undefined |
| 2018 | 7.94 B undefined | 296.43 M undefined | 313.66 M undefined |
| 2017 | 4.72 B undefined | 89.44 M undefined | 101.31 M undefined |
| 2016 | 3.46 B undefined | -46.35 M undefined | 25.9 M undefined |
| 2015 | 2.17 B undefined | -371.85 M undefined | -187.89 M undefined |
| 2014 | 1.62 B undefined | -28 M undefined | 9 M undefined |
| 2013 | 1.53 B undefined | 217 M undefined | 269 M undefined |
| 2012 | 1.23 B undefined | 71 M undefined | 60 M undefined |
| 2011 | 1.01 B undefined | -44 M undefined | -47 M undefined |
| 2010 | 959 M undefined | -64 M undefined | 15 M undefined |
| 2009 | 734 M undefined | -265 M undefined | -208 M undefined |
| 2008 | 811 M undefined | -452 M undefined | -455 M undefined |
| 2007 | 1.11 B undefined | -162 M undefined | -130 M undefined |
| 2006 | 1.2 B undefined | 173 M undefined | 106 M undefined |
| 2005 | 706 M undefined | 4 M undefined | 19 M undefined |
| 2004 | 512 M undefined | -23 M undefined | 3 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 512 M JPY | -23 M JPY | 3 M JPY |
| 2005 | 706 M JPY | 4 M JPY | 19 M JPY |
| 2006 | 1.2 B JPY | 173 M JPY | 106 M JPY |
| 2007 | 1.11 B JPY | -162 M JPY | -130 M JPY |
| 2008 | 811 M JPY | -452 M JPY | -455 M JPY |
| 2009 | 734 M JPY | -265 M JPY | -208 M JPY |
| 2010 | 959 M JPY | -64 M JPY | 15 M JPY |
| 2011 | 1.01 B JPY | -44 M JPY | -47 M JPY |
| 2012 | 1.23 B JPY | 71 M JPY | 60 M JPY |
| 2013 | 1.53 B JPY | 217 M JPY | 269 M JPY |
| 2014 | 1.62 B JPY | -28 M JPY | 9 M JPY |
| 2015 | 2.17 B JPY | -371.85 M JPY | -187.89 M JPY |
| 2016 | 3.46 B JPY | -46.35 M JPY | 25.9 M JPY |
| 2017 | 4.72 B JPY | 89.44 M JPY | 101.31 M JPY |
| 2018 | 7.94 B JPY | 296.43 M JPY | 313.66 M JPY |
| 2019 | 10.53 B JPY | 576.25 M JPY | 499.85 M JPY |
| 2020 | 15.35 B JPY | 740.02 M JPY | 690.95 M JPY |
| 2021 | 46.75 B JPY | 5.67 B JPY | 3.84 B JPY |
| 2022 | 60.19 B JPY | 1.08 B JPY | -374 M JPY |
| 2023 | 68.57 B JPY | 3.61 B JPY | 3.08 B JPY |
Pharma Foods International Co stock margins JP3802310007 ·
The Pharma Foods International Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Pharma Foods International Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Pharma Foods International Co.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Pharma Foods International Co's sales revenue. A higher gross margin percentage indicates that the Pharma Foods International Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Pharma Foods International Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Pharma Foods International Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Pharma Foods International Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Pharma Foods International Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Pharma Foods International Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Pharma Foods International Co Margin History
| Pharma Foods International Co Gross margin | Pharma Foods International Co Profit margin | Pharma Foods International Co EBIT margin | Pharma Foods International Co Profit margin |
|---|---|---|---|
| 2023 | 80.61 % | 5.26 % | 4.49 % |
| 2022 | 79.93 % | 1.79 % | -0.62 % |
| 2021 | 84.97 % | 12.13 % | 8.22 % |
| 2020 | 79.3 % | 4.82 % | 4.5 % |
| 2019 | 81.05 % | 5.47 % | 4.75 % |
| 2018 | 79.96 % | 3.73 % | 3.95 % |
| 2017 | 78.69 % | 1.89 % | 2.15 % |
| 2016 | 71.05 % | -1.34 % | 0.75 % |
| 2015 | 63.64 % | -17.17 % | -8.68 % |
| 2014 | 55.85 % | -1.73 % | 0.56 % |
| 2013 | 58.62 % | 14.23 % | 17.64 % |
| 2012 | 46.29 % | 5.8 % | 4.9 % |
| 2011 | 41.41 % | -4.37 % | -4.67 % |
| 2010 | 46.19 % | -6.67 % | 1.56 % |
| 2009 | 33.38 % | -36.1 % | -28.34 % |
| 2008 | 34.03 % | -55.73 % | -56.1 % |
| 2007 | 59.21 % | -14.62 % | -11.73 % |
| 2006 | 57.92 % | 14.42 % | 8.83 % |
| 2005 | 50.99 % | 0.57 % | 2.69 % |
| 2004 | 50.98 % | -4.49 % | 0.59 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 50.98 % | -4.49 % | 0.59 % |
| 2005 | 50.99 % | 0.57 % | 2.69 % |
| 2006 | 57.92 % | 14.42 % | 8.83 % |
| 2007 | 59.21 % | -14.62 % | -11.73 % |
| 2008 | 34.03 % | -55.73 % | -56.1 % |
| 2009 | 33.38 % | -36.1 % | -28.34 % |
| 2010 | 46.19 % | -6.67 % | 1.56 % |
| 2011 | 41.41 % | -4.37 % | -4.67 % |
| 2012 | 46.29 % | 5.8 % | 4.9 % |
| 2013 | 58.62 % | 14.23 % | 17.64 % |
| 2014 | 55.85 % | -1.73 % | 0.56 % |
| 2015 | 63.64 % | -17.17 % | -8.68 % |
| 2016 | 71.05 % | -1.34 % | 0.75 % |
| 2017 | 78.69 % | 1.89 % | 2.15 % |
| 2018 | 79.96 % | 3.73 % | 3.95 % |
| 2019 | 81.05 % | 5.47 % | 4.75 % |
| 2020 | 79.3 % | 4.82 % | 4.5 % |
| 2021 | 84.97 % | 12.13 % | 8.22 % |
| 2022 | 79.93 % | 1.79 % | -0.62 % |
| 2023 | 80.61 % | 5.26 % | 4.49 % |
Pharma Foods International Co Aktienanalyse
What does Pharma Foods International Co do?
Pharma Foods International Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Pharma Foods International Co's EBIT
Pharma Foods International Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Pharma Foods International Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Pharma Foods International Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Pharma Foods International Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Pharma Foods International Co stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Pharma Foods International Co.
How has the EBIT of Pharma Foods International Co developed in recent years?
The EBIT of Pharma Foods International Co has increased by 234.259% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Pharma Foods International Co?
The EBIT of Pharma Foods International Co is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Pharma Foods International Co pay?
Over the past 12 months, Pharma Foods International Co paid a dividend of 22 JPY . This corresponds to a dividend yield of about 2.26 %. For the coming 12 months, Pharma Foods International Co is expected to pay a dividend of 22 JPY.
What is the dividend yield of Pharma Foods International Co?
The current dividend yield of Pharma Foods International Co is 2.26 %.
When does Pharma Foods International Co pay dividends?
Pharma Foods International Co pays a quarterly dividend. This is distributed in the months of February, August, February, August.
How secure is the dividend of Pharma Foods International Co?
Pharma Foods International Co paid dividends every year for the past 4 years.
What is the dividend of Pharma Foods International Co?
For the upcoming 12 months, dividends amounting to 22 JPY are expected. This corresponds to a dividend yield of 2.26 %.
In which sector is Pharma Foods International Co located?
Pharma Foods International Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Pharma Foods International Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Pharma Foods International Co from 10/1/2024 amounting to 15 JPY, you needed to have the stock in your portfolio before the ex-date on 7/30/2024.
When did Pharma Foods International Co pay the last dividend?
The last dividend was paid out on 10/1/2024.
What was the dividend of Pharma Foods International Co in the year 2023?
In the year 2023, Pharma Foods International Co distributed 20 JPY as dividends.
In which currency does Pharma Foods International Co pay out the dividend?
The dividends of Pharma Foods International Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Pharma Foods International Co
Our stock analysis for Pharma Foods International Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharma Foods International Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Pharma Foods International Co Revenue
- Pharma Foods International Co Net Income
- Pharma Foods International Co P/E
- Pharma Foods International Co P/S
- Pharma Foods International Co EBIT
- Pharma Foods International Co Dividend
- Pharma Foods International Co Stocks
- Pharma Foods International Co Market capitalization
- Pharma Foods International Co Debt
- Pharma Foods International Co Liabilities
- Pharma Foods International Co Equity
- Pharma Foods International Co AAQS
- Pharma Foods International Co Employees
- Pharma Foods International Co ROE
- Pharma Foods International Co ROA
- Pharma Foods International Co ROCE